Prognosis of non-ST-segment elevation acute coronary syndrome in patients with prior percutaneous coronary

José Ferreira Santos1, Jorge Ferreira, Carlos Aguiar

  • 1Serviço de Cardiologia do Hospital de Santa Cruz, Carnaxide, Portugal.

Insights

A prior history of percutaneous coronary intervention (PCI) within four months predicts adverse outcomes in non-ST-segment elevation acute coronary syndromes (ACS) patients. Restenosis is a frequent culprit lesion in this high-risk group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Disagreement exists on the prognostic significance of prior percutaneous coronary intervention (PCI) in non-ST-segment elevation acute coronary syndromes (ACS).
  • Characterizing patients with prior PCI and assessing its impact on prognosis is crucial for risk stratification.

Purpose of the Study:

  • To investigate the prognostic value of a prior history of PCI in patients presenting with ACS.
  • To evaluate the impact of the time interval between prior PCI and the index ACS event on patient outcomes.

Main Methods:

  • A cohort of 448 ACS patients admitted between 1998 and 2000 was analyzed.
  • Patients with prior PCI were compared to those without regarding baseline characteristics.
  • One-year follow-up assessed the composite endpoint of death or myocardial infarction.

Main Results:

  • 134 patients (30%) had a history of prior PCI.
  • Prior PCI was not an independent predictor of one-year adverse events overall.
  • However, PCI within 117 days prior to admission was an independent predictor of adverse outcome (adjusted OR 4.81; p=0.006).
  • Restenosis was the most frequent culprit lesion in patients with recent prior PCI (60% vs 30%; p=0.003).

Conclusions:

  • A history of PCI within the preceding four months is an independent predictor of adverse one-year outcomes in ACS patients.
  • Recent PCI may indicate a higher risk subgroup, potentially due to restenosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...